The Valley Desk

NCT03190915 · Interventional trial

Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

Overall registry status Active not recruiting

Phase 2

Conditions Juvenile Myelomonocytic Leukemia, Neurofibromatosis Type 1

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov